23,924 Shares in Phreesia (NYSE:PHR) Bought by Dean Capital Investments Management LLC

Dean Capital Investments Management LLC acquired a new position in shares of Phreesia (NYSE:PHR) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 23,924 shares of the company’s stock, valued at approximately $580,000. Dean Capital Investments Management LLC owned approximately 0.07% of Phreesia at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Russell Investments Group Ltd. acquired a new position in Phreesia during the third quarter worth $47,000. Tower Research Capital LLC TRC acquired a new position in Phreesia during the third quarter worth $68,000. Rhumbline Advisers acquired a new position in Phreesia during the third quarter worth $208,000. Emerald Advisers LLC acquired a new position in Phreesia during the third quarter worth $1,036,000. Finally, Massachusetts Financial Services Co. MA acquired a new position in Phreesia during the third quarter worth $11,955,000. Institutional investors and hedge funds own 5.57% of the company’s stock.

PHR has been the topic of several analyst reports. ValuEngine downgraded shares of Phreesia from a “buy” rating to a “hold” rating in a research report on Thursday, October 31st. William Blair initiated coverage on shares of Phreesia in a research report on Monday, August 12th. They set an “outperform” rating on the stock. Robert W. Baird initiated coverage on shares of Phreesia in a research report on Thursday, October 10th. They set an “outperform” rating and a $31.00 target price on the stock. JPMorgan Chase & Co. initiated coverage on shares of Phreesia in a research report on Tuesday, August 13th. They set an “overweight” rating and a $33.00 target price on the stock. Finally, Chardan Capital started coverage on shares of Phreesia in a research report on Tuesday, July 23rd. They set a “buy” rating and a $33.00 target price on the stock. One analyst has rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the stock. Phreesia currently has an average rating of “Buy” and a consensus price target of $30.60.

Shares of NYSE:PHR traded down $0.06 during midday trading on Tuesday, hitting $28.50. The company’s stock had a trading volume of 1,306 shares, compared to its average volume of 186,408. Phreesia has a fifty-two week low of $22.05 and a fifty-two week high of $31.00. The stock’s 50 day moving average is $27.17. The company has a debt-to-equity ratio of 0.21, a quick ratio of 3.52 and a current ratio of 3.52.

Phreesia (NYSE:PHR) last released its earnings results on Monday, September 9th. The company reported ($10.42) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($10.30). The company had revenue of $30.82 million during the quarter, compared to analyst estimates of $30.05 million. As a group, equities analysts predict that Phreesia will post -0.56 EPS for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments.

Recommended Story: How Do Tariffs Affect Trade Balances?

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia (NYSE:PHR).

Institutional Ownership by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.